OmniAb Investor Conference Presentation Deck

OmniAb, Inc. OUR BUSINESS MODEL IS FOCUSED ON LICENSING OUR PROPRIETARY DISCOVERY TECHNOLOGY ONE OF THE LARGEST GREENFIELDS IN THE PHARMA INDUSTRY $236 BILLION TOTAL ADDRESSABLE MARKET FOR ANTIBODIES BY 2025 LEADING AND PROVEN TECHNOLOGY GROWING ROSTER OF PARTNERS GROWING NUMBER OF PROGRAMS RECENT PRODUCT APPROVALS GLOBALLY-RECOGNIZED SCIENCE AND TEAM HISTORY OF FIRSTS IN GENETIC ENGINEERING EXPANDING TECHNOLOGY AND CAPABILITIES WE ARE MEETING A GLOBAL INDUSTRY NEED, POISED FOR GROWTH 3 OmniAb

View entire presentation